179 related articles for article (PubMed ID: 12534360)
21. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
Pulkkanen KJ; Parkkinen JJ; Laukkanen JM; Kettunen MI; Tyynela K; Kauppinen RA; Ala-Opas MY; Yla-Herttuala S
Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775
[TBL] [Abstract][Full Text] [Related]
22. [The mechanism of bystander effect in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy].
Zhang L; Liu T; Cui Q; Gao J
Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):440-4. PubMed ID: 11869559
[TBL] [Abstract][Full Text] [Related]
23. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals.
Su H; Lu R; Ding R; Kan YW
Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975
[TBL] [Abstract][Full Text] [Related]
24. Coexpression of a multidrug resistance gene (MDR1) and herpes simplex virus thymidine kinase gene in a bicistronic retroviral vector Ha-MDR-IRES-TK allows selective killing of MDR1-transduced human tumors transplanted in nude mice.
Sugimoto Y; Sato S; Tsukahara S; Suzuki M; Okochi E; Gottesman MM; Pastan I; Tsuruo T
Cancer Gene Ther; 1997; 4(1):51-8. PubMed ID: 9012451
[TBL] [Abstract][Full Text] [Related]
25. DNA-liposome complexes transduction of herpes simplex virus thymidine kinase renders human tongue cancer cell line sensitive to ganciclovir in vitro.
Wang JH; Situ ZQ; Wu JZ; Liu B
Chin J Dent Res; 2000 Dec; 3(4):44-8. PubMed ID: 11314087
[TBL] [Abstract][Full Text] [Related]
26. Gene therapy of established medullary thyroid carcinoma with herpes simplex viral thymidine kinase in a rat tumor model: relationship of bystander effect and antitumor efficacy.
Zhang R; DeGroot LJ
Thyroid; 2000 Apr; 10(4):313-9. PubMed ID: 10807059
[TBL] [Abstract][Full Text] [Related]
27. Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma.
Kuriyama S; Nakatani T; Masui K; Sakamoto T; Tominaga K; Yoshikawa M; Fukui H; Ikenaka K; Tsujii T
Hepatology; 1995 Dec; 22(6):1838-46. PubMed ID: 7489996
[TBL] [Abstract][Full Text] [Related]
28. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect".
Chen CY; Chang YN; Ryan P; Linscott M; McGarrity GJ; Chiang YL
Hum Gene Ther; 1995 Nov; 6(11):1467-76. PubMed ID: 8573619
[TBL] [Abstract][Full Text] [Related]
29. Bystander-mediated regression of osteosarcoma via retroviral transfer of the herpes simplex virus thymidine kinase and human interleukin-2 genes.
Walling HW; Swarthout JT; Culver KW
Cancer Gene Ther; 2000 Feb; 7(2):187-96. PubMed ID: 10770626
[TBL] [Abstract][Full Text] [Related]
30. Co-transduction of herpes simplex virus thymidine kinase gene and human interleukin-2 gene into mouse ovarian cancer cell line, OVHM.
Yamaguchi Y; Takashima I; Hihara J; Ohta K; Shimizu K; Minami K; Yoshida K; Toge T
Int J Mol Med; 2000 Aug; 6(2):185-90. PubMed ID: 10891564
[TBL] [Abstract][Full Text] [Related]
31. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
Wildner O; Blaese RM; Morris JC
Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896
[TBL] [Abstract][Full Text] [Related]
32. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
Kruse CA; Lamb C; Hogan S; Smiley WR; Kleinschmidt-Demasters BK; Burrows FJ
Cancer Gene Ther; 2000 Jan; 7(1):118-27. PubMed ID: 10678364
[TBL] [Abstract][Full Text] [Related]
33. Bystander tumoricidal effect in the treatment of experimental brain tumors.
Wu JK; Cano WG; Meylaerts SA; Qi P; Vrionis F; Cherington V
Neurosurgery; 1994 Dec; 35(6):1094-102; discussion 1102-3. PubMed ID: 7885554
[TBL] [Abstract][Full Text] [Related]
34. Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification.
Couderc BC; de Neuville S; Douin-Echinard V; Serres B; Manenti S; Darbon JM; Malecaze F
Curr Eye Res; 1999 Dec; 19(6):472-82. PubMed ID: 10550788
[TBL] [Abstract][Full Text] [Related]
35. An adenoviral vector expressing functional heterogeneous proteins herpes simplex viral thymidine kinase and human interleukin-2 has enhanced in vivo antitumor activity against medullary thyroid carcinoma.
Zhang R; DeGroot LJ
Endocr Relat Cancer; 2001 Dec; 8(4):315-25. PubMed ID: 11733228
[TBL] [Abstract][Full Text] [Related]
36. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
Rogers RP; Ge JQ; Holley-Guthrie E; Hoganson DK; Comstock KE; Olsen JC; Kenney S
Hum Gene Ther; 1996 Dec; 7(18):2235-45. PubMed ID: 8953314
[TBL] [Abstract][Full Text] [Related]
37. Perspectives for the gene therapy of malignant gliomas by suicide gene transfer.
Di Meco F; Benedetti S; Colombo MP; Finocchiaro G
J Neurosurg Sci; 1997 Sep; 41(3):227-34. PubMed ID: 9444575
[TBL] [Abstract][Full Text] [Related]
38. The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells.
Freeman SM; Ramesh R; Shastri M; Munshi A; Jensen AK; Marrogi AJ
Cancer Lett; 1995 Jun; 92(2):167-74. PubMed ID: 7600527
[TBL] [Abstract][Full Text] [Related]
39. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
Zhao Y; Zhang X; Hui H
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424
[TBL] [Abstract][Full Text] [Related]
40. Lack of bystander killing in herpes simplex virus thymidine kinase-transduced colon cell lines due to deficient connexin43 gap junction formation.
McMasters RA; Saylors RL; Jones KE; Hendrix ME; Moyer MP; Drake RR
Hum Gene Ther; 1998 Oct; 9(15):2253-61. PubMed ID: 9794209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
